Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |